Review



procollagen 1 levels  (TaKaRa)


Bioz Verified Symbol TaKaRa is a verified supplier
Bioz Manufacturer Symbol TaKaRa manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    TaKaRa procollagen 1 levels
    Procollagen 1 Levels, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 213 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/procollagen+1+levels/Procollagen+Type+I+C-Peptide+(PIP)+EIA+Kit/pm23786618-43-4-7
    Average 96 stars, based on 213 article reviews
    procollagen 1 levels - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    other:

    Article Title: Practical application of cellular bioenergetics to the care of aged skin.
    Article Snippet: In human skin fibroblasts in vitro, procollagen-1 and NAD/NADH were reduced in three strains of adult fibroblasts compared with neonatal fibroblasts.. The levels of both procollagen-1 and NAD/NADH were increased in the adult fibroblasts by treatment for 24 (NAD energy) or 48 h (procollagen-1) with a complex containing niacinamide, Pal-KTTKS peptide and an olive oil fatty acid derivative (Olivem ), especially in combination with a natural extract from dill (Lys’lastine V ).. In one of the adult fibroblast strains evaluated, these changes in procollagen-1 and NAD/NADH in response to the complex of bioactives were in parallel with increased expression of mRNA biomarkers related primarily to dermal matrix and basement membrane structure, including COL1A1, COL3A1, COL5A1, COL14A1, ELN and LOXL2, in addition to SOD2, NAMPT and TGFBR3; MMP1 was decreased in expression.



    Similar Products

    type i procollagen levels  (R&D Systems)
    96
    R&D Systems type i procollagen levels
    Type I Procollagen Levels, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/procollagen+1+levels/Human+Pro-Collagen+I+alpha+1+DuoSet+ELISA/pm41351364-49-43-55
    Average 96 stars, based on 1 article reviews
    type i procollagen levels - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    elisa analysis for the n‐terminal propeptide of type 1 procollagen (p1np) levels  (Immunodiagnostic Systems)
    90
    Immunodiagnostic Systems elisa analysis for the n‐terminal propeptide of type 1 procollagen (p1np) levels
    Infused PTH (1–34) and abaloparatide similarly stimulated trabecular osteoblast activity in mice. ( A , B ) Femoral thin sections (5 μm) were stained with Masson's trichrome. ( A ) Representative images of trabecular bone. Measurements were conducted in the secondary spongiosa for histomorphometry analysis of ( B ) osteoid volume (OV/BV). ( C ) At the end of the treatments, sera were collected. To analyze bone formation, <t>serum</t> <t>P1NP</t> levels were measured by <t>ELISA.</t> ( D – M ) Mice were injected with tetracycline at day 4 and with calcein at day 1 before death to determine bone formation. Femoral thin sections (10 μm) were obtained. ( D ) Representative images of right femurs showing differences in double labeling in trabecular bone in mice treated with infused PTH (1–34) or abaloparatide. Measurements were performed in the secondary spongiosa for trabecular dynamic analyses: ( E ) mineralizing surface, ( F ) mineral apposition rate, and ( G ) bone formation rate. Seven to ten mice per group, results are means ± SD. Histomorphometry data were analyzed for normality and equivalence of variance before a one‐way ANOVA followed by Tukey's multiple comparison test ( E ). Some analyses did not show an equivalence of variances or normality, so a rank transformation was done before performing new normality and equivalence of variance tests and then a one‐way ANOVA followed by Tukey's multiple comparison test ( C , G ). Others did not show equivalence of variance and/or a normal distribution so we used Kruskal–Wallis, a nonparametric test ( B , F ). For greater transparency, ANOVA results ( F and p values) or Kruskal–Wallis p values as well as individual p values (0.01 > p > 0.001) were provided in each panel. p < 0.05 was considered significant, and such values are shown in red.
    Elisa Analysis For The N‐Terminal Propeptide Of Type 1 Procollagen (P1np) Levels, supplied by Immunodiagnostic Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/procollagen+1+levels/p1np/pmc09893269-66-5-17
    Average 90 stars, based on 1 article reviews
    elisa analysis for the n‐terminal propeptide of type 1 procollagen (p1np) levels - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    serum levels of p1np (procollagen 1 n-terminal peptide)  (Quest Diagnostics)
    90
    Quest Diagnostics serum levels of p1np (procollagen 1 n-terminal peptide)
    Infused PTH (1–34) and abaloparatide similarly stimulated trabecular osteoblast activity in mice. ( A , B ) Femoral thin sections (5 μm) were stained with Masson's trichrome. ( A ) Representative images of trabecular bone. Measurements were conducted in the secondary spongiosa for histomorphometry analysis of ( B ) osteoid volume (OV/BV). ( C ) At the end of the treatments, sera were collected. To analyze bone formation, <t>serum</t> <t>P1NP</t> levels were measured by <t>ELISA.</t> ( D – M ) Mice were injected with tetracycline at day 4 and with calcein at day 1 before death to determine bone formation. Femoral thin sections (10 μm) were obtained. ( D ) Representative images of right femurs showing differences in double labeling in trabecular bone in mice treated with infused PTH (1–34) or abaloparatide. Measurements were performed in the secondary spongiosa for trabecular dynamic analyses: ( E ) mineralizing surface, ( F ) mineral apposition rate, and ( G ) bone formation rate. Seven to ten mice per group, results are means ± SD. Histomorphometry data were analyzed for normality and equivalence of variance before a one‐way ANOVA followed by Tukey's multiple comparison test ( E ). Some analyses did not show an equivalence of variances or normality, so a rank transformation was done before performing new normality and equivalence of variance tests and then a one‐way ANOVA followed by Tukey's multiple comparison test ( C , G ). Others did not show equivalence of variance and/or a normal distribution so we used Kruskal–Wallis, a nonparametric test ( B , F ). For greater transparency, ANOVA results ( F and p values) or Kruskal–Wallis p values as well as individual p values (0.01 > p > 0.001) were provided in each panel. p < 0.05 was considered significant, and such values are shown in red.
    Serum Levels Of P1np (Procollagen 1 N Terminal Peptide), supplied by Quest Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/procollagen+1+levels/c+telopeptide/pm35429657-82-11-4
    Average 90 stars, based on 1 article reviews
    serum levels of p1np (procollagen 1 n-terminal peptide) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    procollagen 1 levels  (TaKaRa)
    96
    TaKaRa procollagen 1 levels
    Infused PTH (1–34) and abaloparatide similarly stimulated trabecular osteoblast activity in mice. ( A , B ) Femoral thin sections (5 μm) were stained with Masson's trichrome. ( A ) Representative images of trabecular bone. Measurements were conducted in the secondary spongiosa for histomorphometry analysis of ( B ) osteoid volume (OV/BV). ( C ) At the end of the treatments, sera were collected. To analyze bone formation, <t>serum</t> <t>P1NP</t> levels were measured by <t>ELISA.</t> ( D – M ) Mice were injected with tetracycline at day 4 and with calcein at day 1 before death to determine bone formation. Femoral thin sections (10 μm) were obtained. ( D ) Representative images of right femurs showing differences in double labeling in trabecular bone in mice treated with infused PTH (1–34) or abaloparatide. Measurements were performed in the secondary spongiosa for trabecular dynamic analyses: ( E ) mineralizing surface, ( F ) mineral apposition rate, and ( G ) bone formation rate. Seven to ten mice per group, results are means ± SD. Histomorphometry data were analyzed for normality and equivalence of variance before a one‐way ANOVA followed by Tukey's multiple comparison test ( E ). Some analyses did not show an equivalence of variances or normality, so a rank transformation was done before performing new normality and equivalence of variance tests and then a one‐way ANOVA followed by Tukey's multiple comparison test ( C , G ). Others did not show equivalence of variance and/or a normal distribution so we used Kruskal–Wallis, a nonparametric test ( B , F ). For greater transparency, ANOVA results ( F and p values) or Kruskal–Wallis p values as well as individual p values (0.01 > p > 0.001) were provided in each panel. p < 0.05 was considered significant, and such values are shown in red.
    Procollagen 1 Levels, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/procollagen+1+levels/Procollagen+Type+I+C-Peptide+(PIP)+EIA+Kit/pm23786618-43-4-7
    Average 96 stars, based on 1 article reviews
    procollagen 1 levels - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    Infused PTH (1–34) and abaloparatide similarly stimulated trabecular osteoblast activity in mice. ( A , B ) Femoral thin sections (5 μm) were stained with Masson's trichrome. ( A ) Representative images of trabecular bone. Measurements were conducted in the secondary spongiosa for histomorphometry analysis of ( B ) osteoid volume (OV/BV). ( C ) At the end of the treatments, sera were collected. To analyze bone formation, serum P1NP levels were measured by ELISA. ( D – M ) Mice were injected with tetracycline at day 4 and with calcein at day 1 before death to determine bone formation. Femoral thin sections (10 μm) were obtained. ( D ) Representative images of right femurs showing differences in double labeling in trabecular bone in mice treated with infused PTH (1–34) or abaloparatide. Measurements were performed in the secondary spongiosa for trabecular dynamic analyses: ( E ) mineralizing surface, ( F ) mineral apposition rate, and ( G ) bone formation rate. Seven to ten mice per group, results are means ± SD. Histomorphometry data were analyzed for normality and equivalence of variance before a one‐way ANOVA followed by Tukey's multiple comparison test ( E ). Some analyses did not show an equivalence of variances or normality, so a rank transformation was done before performing new normality and equivalence of variance tests and then a one‐way ANOVA followed by Tukey's multiple comparison test ( C , G ). Others did not show equivalence of variance and/or a normal distribution so we used Kruskal–Wallis, a nonparametric test ( B , F ). For greater transparency, ANOVA results ( F and p values) or Kruskal–Wallis p values as well as individual p values (0.01 > p > 0.001) were provided in each panel. p < 0.05 was considered significant, and such values are shown in red.

    Journal: JBMR Plus

    Article Title: Abaloparatide Has the Same Catabolic Effects on Bones of Mice When Infused as PTH (1–34)

    doi: 10.1002/jbm4.10710

    Figure Lengend Snippet: Infused PTH (1–34) and abaloparatide similarly stimulated trabecular osteoblast activity in mice. ( A , B ) Femoral thin sections (5 μm) were stained with Masson's trichrome. ( A ) Representative images of trabecular bone. Measurements were conducted in the secondary spongiosa for histomorphometry analysis of ( B ) osteoid volume (OV/BV). ( C ) At the end of the treatments, sera were collected. To analyze bone formation, serum P1NP levels were measured by ELISA. ( D – M ) Mice were injected with tetracycline at day 4 and with calcein at day 1 before death to determine bone formation. Femoral thin sections (10 μm) were obtained. ( D ) Representative images of right femurs showing differences in double labeling in trabecular bone in mice treated with infused PTH (1–34) or abaloparatide. Measurements were performed in the secondary spongiosa for trabecular dynamic analyses: ( E ) mineralizing surface, ( F ) mineral apposition rate, and ( G ) bone formation rate. Seven to ten mice per group, results are means ± SD. Histomorphometry data were analyzed for normality and equivalence of variance before a one‐way ANOVA followed by Tukey's multiple comparison test ( E ). Some analyses did not show an equivalence of variances or normality, so a rank transformation was done before performing new normality and equivalence of variance tests and then a one‐way ANOVA followed by Tukey's multiple comparison test ( C , G ). Others did not show equivalence of variance and/or a normal distribution so we used Kruskal–Wallis, a nonparametric test ( B , F ). For greater transparency, ANOVA results ( F and p values) or Kruskal–Wallis p values as well as individual p values (0.01 > p > 0.001) were provided in each panel. p < 0.05 was considered significant, and such values are shown in red.

    Article Snippet: The samples were frozen before ELISA analysis for the N‐terminal propeptide of type 1 procollagen (P1NP) levels (Immunodiagnostic Systems Inc., Boldon, UK) or the C‐terminal crosslinking telopeptide of type I collagen (CTX, Immunodiagnostic Systems Inc., Boldon, UK).

    Techniques: Activity Assay, Staining, Enzyme-linked Immunosorbent Assay, Injection, Labeling, Comparison, Transformation Assay